Active, not recruiting
An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease
NCT05899673
- Conditions
- Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- UCSD Altman Clinical and Translational Research Institute La Jolla, California, United States
- Stanford Medicine Outpatient Center Redwood City, California, United States
- UF Clinical and Translational Science Institute Gainesville, Florida, United States
- University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States